RainbowChildrenS Med Share Price
Rainbow Children's Medicare Ltd.
Today’s Low
Today’s High
52W Low
52W High
Open Price
Prev. Close
Volume
Value
Market Cap |
P/E Ratio |
P/B Ratio |
Industry P/E |
---|---|---|---|
Rs. 7497.42 Cr |
0.00 |
0.00 |
168.43 |
ROE |
EPS (TTM) |
Dividend Yield |
Book Value |
---|---|---|---|
26.10 % |
15.08 |
0.00 % |
101.55 |
All you have to do to buy Rainbow Children's Medicare Ltd. share is download Nuuu app, create a demat account, and get your KYC documents verified online.
Yes you can buy Rainbow Children's Medicare Ltd. shares, all you need is to have a verified demat account with Nuuu. And enjoy benefits like free brokerage credits and more.
As of 20 Mar`23 the Market Cap of Rainbow Children's Medicare Ltd. is 7497.42.
As of 20 Mar`23 the PE is 0.00 and PB is 0.00.
A fair growth of 18.28% in the revenue at Rs. 2977.90 millions was reported in the September 2022 quarter as compared to Rs. 2517.64 millions during year-ago period.The Company has registered profit of Rs. 558.36 millions for the quarter ended September 2022, a growth of 20.28% over Rs. 464.22 millions millions achieved in the corresponding quarter of last year.Operating Profit saw a handsome growth to 1129.16 millions from 924.32 millions in the quarter ended September 2022.
(Rs. in Million) |
Quarter ended | Year to Date | Year ended | |||||||
202209 | 202109 | % Var | 202209 | 202109 | % Var | 202203 | 202103 | % Var | |
Sales | 2977.90 | 2517.64 | 18.28 | 5205.43 | 4879.69 | 6.68 | 9245.95 | 6144.54 | 50.47 |
Other Income | 79.40 | 54.19 | 46.52 | 143.47 | 80.83 | 77.50 | 208.19 | 119.48 | 74.25 |
PBIDT | 1129.16 | 924.32 | 22.16 | 1967.82 | 1719.35 | 14.45 | 3167.36 | 1754.76 | 80.50 |
Interest | 124.95 | 115.36 | 8.31 | 259.24 | 237.27 | 9.26 | 500.05 | 416.88 | 19.95 |
PBDT | 957.91 | 808.96 | 18.41 | 1662.28 | 1482.08 | 12.16 | 2667.31 | 1337.88 | 99.37 |
Depreciation | 208.18 | 189.69 | 9.75 | 411.13 | 367.41 | 11.90 | 769.87 | 678.95 | 13.39 |
PBT | 749.73 | 619.27 | 21.07 | 1251.15 | 1114.67 | 12.24 | 1897.44 | 658.93 | 187.96 |
TAX | 191.37 | 155.05 | 23.42 | 316.84 | 277.19 | 14.30 | 474.53 | 164.79 | 187.96 |
Deferred Tax | -36.36 | -3.67 | 890.74 | -61.02 | -31.75 | 92.19 | -100.95 | -73.74 | 36.90 |
PAT | 558.36 | 464.22 | 20.28 | 934.31 | 837.48 | 11.56 | 1422.91 | 494.14 | 187.96 |
Equity | 1015.02 | 549.03 | 84.88 | 1015.02 | 549.03 | 84.88 | 1049.98 | 549.03 | 91.24 |
PBIDTM(%) | 37.92 | 36.71 | 3.28 | 37.80 | 35.23 | 7.29 | 34.26 | 28.56 | 19.95 |
The revenue zoomed 23.46% to Rs. 2907.18 millions for the quarter ended December 2022 as compared to Rs. 2354.79 millions during the corresponding quarter last year.Net Profit recorded in the quarter ended December 2022 rise to 28.97% to Rs. 568.77 millions compared to R. 441.00 millions in corresponding previous quarter.The company reported a good operating profit of 1100.48 millions compared to 912.28 millions of corresponding previous quarter.
(Rs. in Million) |
Quarter ended | Year to Date | Year ended | |||||||
202212 | 202112 | % Var | 202212 | 202112 | % Var | 202203 | 202103 | % Var | |
Sales | 2907.18 | 2354.79 | 23.46 | 8112.61 | 7234.48 | 12.14 | 9245.95 | 6144.54 | 50.47 |
Other Income | 82.40 | 61.38 | 34.25 | 225.87 | 142.21 | 58.83 | 208.19 | 119.48 | 74.25 |
PBIDT | 1100.48 | 912.28 | 20.63 | 3068.30 | 2631.63 | 16.59 | 3167.36 | 1754.76 | 80.50 |
Interest | 128.58 | 107.92 | 19.14 | 387.82 | 345.19 | 12.35 | 500.05 | 416.88 | 19.95 |
PBDT | 971.90 | 804.36 | 20.83 | 2634.18 | 2286.44 | 15.21 | 2667.31 | 1337.88 | 99.37 |
Depreciation | 210.25 | 195.59 | 7.50 | 621.38 | 563.00 | 10.37 | 769.87 | 678.95 | 13.39 |
PBT | 761.65 | 608.77 | 25.11 | 2012.80 | 1723.44 | 16.79 | 1897.44 | 658.93 | 187.96 |
TAX | 192.88 | 167.77 | 14.97 | 509.72 | 444.96 | 14.55 | 474.53 | 164.79 | 187.96 |
Deferred Tax | -31.04 | -43.30 | -28.31 | -92.06 | -75.05 | 22.66 | -100.95 | -73.74 | 36.90 |
PAT | 568.77 | 441.00 | 28.97 | 1503.08 | 1278.48 | 17.57 | 1422.91 | 494.14 | 187.96 |
Equity | 1015.02 | 1049.98 | -3.33 | 1015.02 | 1049.98 | -3.33 | 1049.98 | 549.03 | 91.24 |
PBIDTM(%) | 37.85 | 38.74 | -2.29 | 37.82 | 36.38 | 3.97 | 34.26 | 28.56 | 19.95 |
Rainbow Childrens Medicare has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for White Oak Capital Management Consultants LLP.
The above information is a part of company’s filings submitted to BSE.
Rainbow Children's Medicare has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for British International Investment Plc & CDC India Opportunities.
The above information is a part of company’s filings submitted to BSE.
Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 41 of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, Rainbow Children’s Medicare has informed that it enclosed the Monitoring Agency Report dated February 7, 2023, issued by HDFC Bank, Monitoring Agency, for the quarter ended December 31, 2022 in respect of utilization of proceeds of the Initial Public Offer of the Company.
The above information is a part of company’s filings submitted to BSE.
Rainbow Children’s Medicare has informed that it enclosed the Press Release for the Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Nine Months ended December 31, 2022.
The above information is a part of company’s filings submitted to BSE.
Quarterly Results
Quarterly Results
Final Dividend & Audited Results
This hospital will provide comprehensive pediatric and obstetrics services
Rainbow Children’s Medicare (RCML) has inaugurated its latest 55 bed spoke hospital at OMR (Sholinganallur), Chennai, Tamil Nadu. With this development the Company is initiating its hub-and-spoke model of Hyderabad and Bengaluru at Chennai. The hospital located at OMR (Sholinganallur), has been envisaged as a spoke hospital and will serve to strengthen the presence of Rainbow in Chennai.
This hospital will provide comprehensive pediatric and obstetrics services which includes consultant led 24X7 emergency care in pediatrics and obstetrics, outpatient services and level 3 NICU services. The hospital will transfer all complex patients requiring tertiary and quaternary care treatment to the Hub hospital at Guindy thereby emphasizing the multi-disciplinary and collaborative team approach of the RCML brand.
RCML is working constantly to improve its service offering to achieve its goal of providing quality pediatric healthcare across cities. The Company intends to add 1,000 beds in its target cities of Hyderabad, Bengaluru, Chennai, National Capital Region and Tier-2 cities of Andhra Pradesh and Tamil Nadu over the next 5 years.
Rainbow Children’s Medicare’s core specialties are pediatrics, which includes newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care (including multi organ transplants); and obstetrics and gynecology, which includes normal and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility care.
Those who picked up the shares of the company are foreign portfolio investors and domestic mutual fund
British International Investment Plc has sold its entire 14.45 per cent stake in Rainbow Children's Medicare for an estimated Rs 1,078 crore through open market transactions. Those who picked up the shares of the company are foreign portfolio investors and domestic mutual fund.
According to the bulk deal data available with the National Stock Exchange (NSE), British International Investment Plc offloaded a total of 1,46,66,112 shares of the company. The shares were sold at an average price of Rs 735-Rs 735.55 apiece, taking the combined value of the transaction to Rs 1,078.48 crore.
Abu Dhabi Investment Authority, Government of Singapore, Stichting Depositary APG Emerging Markets Equity Pool, India Acorn ICAV - Ashoka India Opportunities Fund and ICICI Prudential Mutual Fund were the buyers of the shares.
Rainbow Children’s Medicare’s core specialties are pediatrics, which includes newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care (including multi organ transplants); and obstetrics and gynecology, which includes normal and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility care.
With this development, the company is further strengthening its presence and reaching a cumulative bed strength of 830 beds in Hyderabad
Rainbow Children’s Medicare (RCML) has inaugurated its latest 100 beds spoke hospital, located at Financial District, Hyderabad, Telangana. This is Rainbow’s 7th hospital in Hyderabad and is strategically located in the rapidly growing financial district of Hyderabad.
With this development, the company is further strengthening its presence and reaching a cumulative bed strength of 830 beds in Hyderabad. The new hospital has been envisaged as a large spoke hospital and will form an important part of the Rainbow network in Hyderabad. This hospital will provide comprehensive pediatric and obstetrics services which includes consultant led 24X7 emergency care in pediatrics and obstetrics, outpatient services and level 3 neonatal and pediatric intensive care services. The hospital will complement the services offered at the Hub hospital at Banjara Hills, Hyderabad.
Rainbow Children’s Medicare’s core specialties are pediatrics, which includes newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care (including multi organ transplants); and obstetrics and gynecology, which includes normal and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility care.